New York · 2025 Regular Session · Bill
S 5352: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 5352 is a bill introduced in the New York Senate on February 20, 2025. According to its official title, it concerns: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product. Primary sponsor: Leroy Comrie (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HIGHER EDUCATION.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Leroy Comrie | Primary sponsor | Democratic | Senate | 14 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HIGHER EDUCATION
- REFERRED TO HIGHER EDUCATION